Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
US6579526B1 · kind B1 · utility
1Cited by
21References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 1999 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Aug 16, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/10022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.